BioNReg CMC Consulting

Executive Summary

BioNReg CMC Consulting is a boutique regulatory affairs consultancy based in Leuven, Belgium, founded in 2019 by Dr. Jean-Marc Wilkin. The firm specializes in Chemistry, Manufacturing, and Controls (CMC) for biological products, offering scientific advice, dossier authoring, and management support across the product lifecycle. As an independent freelancer-led operation, BioNReg serves biopharmaceutical and biotech clients navigating complex regulatory pathways from development through post-approval. Despite a modest profile, the company's deep expertise in biologics CMC positions it as a niche player in a growing regulatory outsourcing market. With no disclosed funding, small employee base, and limited public visibility, its impact is measured through client engagements rather than scale. The consultancy is well-placed to benefit from increasing regulatory demands for biosimilars and advanced therapies, but growth is constrained by its single-founder model.

Upcoming Catalysts (preview)

• TBDExpansion of biosimilar CMC consulting demand in Europe70% success
• TBDPotential partnership with larger CRO or regulatory network30% success
• TBDPublication of thought leadership or case studies on biologics CMC60% success